{"log_id": 5860320831846530277, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 0, "average": 0.999758, "min": 0.999219}, "location": {"width": 126, "top": 198, "height": 32, "left": 203}, "words": "实验室检查"}, {"probability": {"variance": 7e-06, "average": 0.99657, "min": 0.9929}, "location": {"width": 148, "top": 246, "height": 29, "left": 208}, "words": "磷酸西格列汀"}, {"probability": {"variance": 0.000154, "average": 0.994129, "min": 0.944809}, "location": {"width": 832, "top": 277, "height": 48, "left": 205}, "words": "在接受西格列汀和二甲双胍治疗的患者中实验室不良反应的发生率(7.6%)与接"}, {"probability": {"variance": 0, "average": 0.850995, "min": 0.850995}, "location": {"width": 20, "top": 303, "height": 24, "left": 1182}, "words": "5"}, {"probability": {"variance": 2.2e-05, "average": 0.996958, "min": 0.977275}, "location": {"width": 830, "top": 325, "height": 48, "left": 207}, "words": "受安慰剂和二甲双胍治疗的患者(8.7%)相似。在大多数但不是所有研究中,由"}, {"probability": {"variance": 0.00028, "average": 0.99349, "min": 0.901718}, "location": {"width": 818, "top": 373, "height": 46, "left": 211}, "words": "于嗜中性粒细胞小幅度增加,观察到白细胞计数出现小幅度增加(相对于安慰剂"}, {"probability": {"variance": 0.016355, "average": 0.955823, "min": 0.441319}, "location": {"width": 816, "top": 421, "height": 46, "left": 210}, "words": "白细胞的差异大约为200细胞/μL;白细胞的基线平均值大约为600细胞/L)"}, {"probability": {"variance": 7e-05, "average": 0.996675, "min": 0.964117}, "location": {"width": 413, "top": 475, "height": 40, "left": 210}, "words": "实验室参数的变化被视为没有临床意义"}, {"probability": {"variance": 0.031471, "average": 0.910022, "min": 0.514223}, "location": {"width": 148, "top": 529, "height": 33, "left": 215}, "words": "盐酸二甲双肌"}, {"probability": {"variance": 3e-06, "average": 0.998895, "min": 0.994045}, "location": {"width": 830, "top": 563, "height": 45, "left": 213}, "words": "在二甲双胍的一项为期29周的对照试验中,在大约7%的患者中观察到既往正常"}, {"probability": {"variance": 0.002294, "average": 0.988165, "min": 0.699475}, "location": {"width": 828, "top": 609, "height": 48, "left": 215}, "words": "的维生素B12血清浓度降低到正常水平以下,但没有临床表现。这种维生素B12水"}, {"probability": {"variance": 0.005321, "average": 0.979736, "min": 0.55109}, "location": {"width": 827, "top": 658, "height": 45, "left": 217}, "words": "平的下降可能是由于二甲双胍干扰了B12-内因子复合物吸收B12所致,然而,该现"}, {"probability": {"variance": 3e-05, "average": 0.997368, "min": 0.974507}, "location": {"width": 830, "top": 704, "height": 47, "left": 216}, "words": "象伴有贫血非常罕见。停用二甲双胍或补充维生素B12后很快缓解(参见注意事"}, {"probability": {"variance": 0.0357, "average": 0.897435, "min": 0.4316}, "location": {"width": 207, "top": 765, "height": 31, "left": 219}, "words": "项一盐酸二甲双"}, {"probability": {"variance": 0, "average": 0.999731, "min": 0.999331}, "location": {"width": 86, "top": 855, "height": 28, "left": 226}, "words": "【禁忌】"}, {"probability": {"variance": 0.022922, "average": 0.936349, "min": 0.486338}, "location": {"width": 508, "top": 892, "height": 43, "left": 222}, "words": "本品(磷酸西格列盐酸二甲双胍)的禁忌包括"}, {"probability": {"variance": 0.019209, "average": 0.939552, "min": 0.390468}, "location": {"width": 842, "top": 934, "height": 49, "left": 220}, "words": "1.肾病或肾功能异常,即血清肌酐水平≥1.5mg/dl(男性)、1.mg(女性),"}, {"probability": {"variance": 0.001575, "average": 0.986942, "min": 0.77866}, "location": {"width": 791, "top": 981, "height": 49, "left": 258}, "words": "或肌酐清除率异常,这些情况也有可能是由循环衰竭(休克)、急性心肌梗"}, {"probability": {"variance": 6e-06, "average": 0.998238, "min": 0.992908}, "location": {"width": 170, "top": 1043, "height": 29, "left": 261}, "words": "死和败血症引起"}, {"probability": {"variance": 0.000341, "average": 0.99132, "min": 0.899253}, "location": {"width": 827, "top": 1076, "height": 47, "left": 223}, "words": "2.已知对磷酸西格列汀、盐酸二甲双胍或本品的任何其它成分过敏(参见注意"}, {"probability": {"variance": 0.000818, "average": 0.987016, "min": 0.869172}, "location": {"width": 609, "top": 1128, "height": 41, "left": 263}, "words": "事项,磷酸西格列汀,过敏反应和不良反应,上市后经验)"}, {"probability": {"variance": 0.003744, "average": 0.986976, "min": 0.633323}, "location": {"width": 818, "top": 1173, "height": 43, "left": 225}, "words": "3.急性或慢性代谢性酸中毒,包括糖尿病酮症酸中毒在内,无论是否伴有昏迷"}, {"probability": {"variance": 0.00635, "average": 0.984681, "min": 0.527299}, "location": {"width": 810, "top": 1221, "height": 41, "left": 228}, "words": "对于接受影像学检查需要血管内注射含碘造影剂的患者,应暂时停止本品治疗"}, {"probability": {"variance": 0.010533, "average": 0.976457, "min": 0.412658}, "location": {"width": 778, "top": 1267, "height": 42, "left": 227}, "words": "因为这类造影剂可能造成急性肾功能改变(参见注意事项:盐酸二甲双"}, {"probability": {"variance": 0, "average": 0.999866, "min": 0.999609}, "location": {"width": 134, "top": 1368, "height": 28, "left": 237}, "words": "【注意事项】"}, {"probability": {"variance": 0.033193, "average": 0.814539, "min": 0.632348}, "location": {"width": 50, "top": 1417, "height": 27, "left": 234}, "words": "本品"}, {"probability": {"variance": 0.000573, "average": 0.99128, "min": 0.899039}, "location": {"width": 513, "top": 1453, "height": 39, "left": 233}, "words": "本品不能用于1型糖尿病或糖尿病酮症酸中毒患者"}, {"probability": {"variance": 1.2e-05, "average": 0.998098, "min": 0.980046}, "location": {"width": 828, "top": 1496, "height": 44, "left": 230}, "words": "胰腺炎:在上市后经验中,接受西格列汀二甲双胍治疗的患者中曾报道了急性胰"}, {"probability": {"variance": 8e-06, "average": 0.998154, "min": 0.986174}, "location": {"width": 829, "top": 1542, "height": 44, "left": 232}, "words": "腺炎,包括致死性和非致死性出血性或坏死性胰腺炎(参见不良反应,上市后经"}], "language": 3}